Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Paratesticular Sarcoma: Typical Presentation, Imaging Features, and Clinical Challenges.

Ap Dafydd D, Messiou C, Thway K, Strauss DC, Nicol DL, Moskovic E.

Urology. 2017 Feb;100:163-168. doi: 10.1016/j.urology.2016.09.005. Epub 2016 Sep 14.

PMID:
27639792
2.

Hypermethylation of the 5' CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis.

Manton KJ, Douglas ML, Netzel-Arnett S, Fitzpatrick DR, Nicol DL, Boyd AW, Clements JA, Antalis TM.

Br J Cancer. 2015 Dec 1;113(11):1640. doi: 10.1038/bjc.2015.384. No abstract available.

3.

Patients Who Receive Androgen Deprivation Therapy Risk Adverse Cognitive Changes.

Gardiner RA, Yaxley J, Pakenham KI, Green H, Mactaggart P, Watson R, Swanson C, Nicol DL.

J Clin Oncol. 2015 Dec 20;33(36):4314-5. doi: 10.1200/JCO.2015.63.5698. Epub 2015 Oct 26. No abstract available.

PMID:
26503208
4.

Clean intermittent self-catheterization does not appear to be effective in the prevention of urethral stricture recurrence.

Greenwell TJ, Castle C, Nicol DL.

Scand J Urol. 2016;50(1):71-3. doi: 10.3109/21681805.2015.1086888. Epub 2015 Oct 1.

PMID:
26428415
5.

Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.

Kovac M, Navas C, Horswell S, Salm M, Bardella C, Rowan A, Stares M, Castro-Giner F, Fisher R, de Bruin EC, Kovacova M, Gorman M, Makino S, Williams J, Jaeger E, Jones A, Howarth K, Larkin J, Pickering L, Gore M, Nicol DL, Hazell S, Stamp G, O'Brien T, Challacombe B, Matthews N, Phillimore B, Begum S, Rabinowitz A, Varela I, Chandra A, Horsfield C, Polson A, Tran M, Bhatt R, Terracciano L, Eppenberger-Castori S, Protheroe A, Maher E, El Bahrawy M, Fleming S, Ratcliffe P, Heinimann K, Swanton C, Tomlinson I.

Nat Commun. 2015 Mar 19;6:6336. doi: 10.1038/ncomms7336.

6.

Multidisciplinary urological engagement in translational renal cancer research.

Stewart GD, Harrison DJ, Swanton C, Lewis R, Bliss J, Larkin J, Nicol DL; A-PREDICT TMG.

BJU Int. 2014 Oct;114(4):474-5. doi: 10.1111/bju.12697. Epub 2014 Jul 28. No abstract available.

7.

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing.

Gerlinger M, Horswell S, Larkin J, Rowan AJ, Salm MP, Varela I, Fisher R, McGranahan N, Matthews N, Santos CR, Martinez P, Phillimore B, Begum S, Rabinowitz A, Spencer-Dene B, Gulati S, Bates PA, Stamp G, Pickering L, Gore M, Nicol DL, Hazell S, Futreal PA, Stewart A, Swanton C.

Nat Genet. 2014 Mar;46(3):225-233. doi: 10.1038/ng.2891. Epub 2014 Feb 2.

8.

PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancer.

Vela I, Morrissey C, Zhang X, Chen S, Corey E, Strutton GM, Nelson CC, Nicol DL, Clements JA, Gardiner EM.

Clin Exp Metastasis. 2014 Feb;31(2):199-211. doi: 10.1007/s10585-013-9620-7. Epub 2013 Oct 26.

PMID:
24162257
9.

Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas.

Gerlinger M, Quezada SA, Peggs KS, Furness AJ, Fisher R, Marafioti T, Shende VH, McGranahan N, Rowan AJ, Hazell S, Hamm D, Robins HS, Pickering L, Gore M, Nicol DL, Larkin J, Swanton C.

J Pathol. 2013 Dec;231(4):424-32. doi: 10.1002/path.4284.

10.

Incidental renal cell carcinoma identified during laparoscopic live-related donor nephrectomy.

Bycroft JA, Benaragama KS, Green A, Lindsey B, Nicol DL.

JRSM Short Rep. 2010 Sep 20;1(4):32. doi: 10.1258/shorts.2010.010039. No abstract available.

11.

Open and laparoscopic donor nephrectomy: activity and outcomes from all Australasian transplant centers.

Brook NR, Gibbons N, Nicol DL, McDonald SP.

Transplantation. 2010 Jun 27;89(12):1482-8. doi: 10.1097/TP.0b013e3181dd35a0.

PMID:
20418804
12.

Expression of PSA-RP2, an alternatively spliced variant from the PSA gene, is increased in prostate cancer tissues but the protein is not secreted from prostate cancer cells.

Whitbread AK, Veveris-Lowe TL, Dong Y, Tan OL, Gardiner R, Samaratunga HM, Nicol DL, Clements JA.

Biol Chem. 2010 Apr;391(4):461-6. doi: 10.1515/BC.2010.043.

PMID:
20180647
13.

Silibinin--a promising new treatment for cancer.

Cheung CW, Gibbons N, Johnson DW, Nicol DL.

Anticancer Agents Med Chem. 2010 Mar;10(3):186-95. Review.

PMID:
20015009
14.

Outcomes of transplants from patients with small renal tumours, live unrelated donors and dialysis wait-listed patients.

Brook NR, Gibbons N, Johnson DW, Nicol DL.

Transpl Int. 2010 May 1;23(5):476-83. doi: 10.1111/j.1432-2277.2009.01002.x. Epub 2009 Dec 8.

15.

Predicting risk of nonmelanoma skin cancer and premalignant skin lesions in renal transplant recipients.

Urwin HR, Jones PW, Harden PN, Ramsay HM, Hawley CM, Nicol DL, Fryer AA.

Transplantation. 2009 Jun 15;87(11):1667-71. doi: 10.1097/TP.0b013e3181a5ce2e.

PMID:
19502958
16.

Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients.

Mudge DW, Tan KS, Miles R, Johnson DW, Campbell SB, Hawley CM, Isbel NM, Van Eps CL, Nicol DL.

BMC Nephrol. 2009 Jun 6;10:14. doi: 10.1186/1471-2369-10-14.

17.

Change in live donor characteristics over the last 25 years: a single centre experience.

Kaisar MO, Nicol DL, Hawley CM, Mudge DW, Johnson DW, Preston JM, Wall DR, Griffin AD, Campbell SB, Isbel NM.

Nephrology (Carlton). 2008 Oct;13(7):646-50. doi: 10.1111/j.1440-1797.2008.01039.x.

PMID:
19161367
18.

Kidneys from patients with small renal tumours: a novel source of kidneys for transplantation.

Nicol DL, Preston JM, Wall DR, Griffin AD, Campbell SB, Isbel NM, Hawley CM, Johnson DW.

BJU Int. 2008 Jul;102(2):188-92; discussion 192-3. doi: 10.1111/j.1464-410X.2008.07562.x. Epub 2008 Jul 1.

19.

Therapeutic value of orally administered silibinin in renal cell carcinoma: manipulation of insulin-like growth factor binding protein-3 levels.

Cheung CW, Taylor PJ, Kirkpatrick CM, Vesey DA, Gobe GC, Winterford C, Nicol DL, Johnson DW.

BJU Int. 2007 Aug;100(2):438-44.

20.

Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases.

Lawrence MG, Veveris-Lowe TL, Whitbread AK, Nicol DL, Clements JA.

Cells Tissues Organs. 2007;185(1-3):111-5. Review.

PMID:
17587816

Supplemental Content

Loading ...
Support Center